UBE2I expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.196000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.791000E-01
Normal-vs-Stage2
8.273800E-01
Normal-vs-Stage3
6.086000E-01
Normal-vs-Stage4
5.334200E-01
Stage1-vs-Stage2
3.324800E-01
Stage1-vs-Stage3
9.513000E-01
Stage1-vs-Stage4
6.749000E-01
Stage2-vs-Stage3
3.799600E-01
Stage2-vs-Stage4
7.228200E-01
Stage3-vs-Stage4
7.764000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.209400E-01
Normal-vs-AfricanAmerican
4.471200E-01
Normal-vs-Asian
5.765400E-01
Caucasian-vs-AfricanAmerican
8.436200E-01
Caucasian-vs-Asian
8.661400E-01
AfricanAmerican-vs-Asian
9.624800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.208800E-01
Normal-vs-Female
6.029000E-01
Male-vs-Female
2.883000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.405400E-01
Normal-vs-Age(41-60Yrs)
9.813200E-01
Normal-vs-Age(61-80Yrs)
5.892600E-01
Normal-vs-Age(81-100Yrs)
9.069000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.902800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.038000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.245600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.936000E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.924600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.952400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.496800E-01
Normal-vs-Daily Drinker
9.616800E-01
Normal-vs-Weekly Drinker
4.935600E-01
Normal-vs-Occasional Drinker
9.759000E-01
Normal-vs-Social Drinker
7.326800E-01
Non Drinker-vs-Daily Drinker
5.828000E-01
Non Drinker-vs-Weekly Drinker
6.827400E-01
Non Drinker-vs-Occasional Drinker
5.176200E-01
Non Drinker-vs-Social Drinker
8.870000E-01
Daily Drinker-vs-Weekly Drinker
3.847800E-01
Daily Drinker-vs-Occasional Drinker
9.536200E-01
Daily Drinker-vs-Social Drinker
7.054200E-01
Weekly Drinker-vs-Occasional Drinker
2.533800E-01
Weekly Drinker-vs-Social Drinker
5.411600E-01
Occasional Drinker-vs-Social Drinker
5.896600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.843600E-01
Normal-vs-Grade 2
4.986000E-01
Normal-vs-Grade 3
2.786400E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
8.42520000000624E-05
Grade 1-vs-Grade 3
2.611300E-04
Grade 1-vs-Grade 4
2.843600E-01
Grade 2-vs-Grade 3
2.399200E-01
Grade 2-vs-Grade 4
4.986000E-01
Grade 3-vs-Grade 4
2.786400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.577200E-01
Normal-vs-NonDiabetic
7.971400E-01
Diabetic-vs-NonDiabetic
3.773600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.918200E-01
Normal-vs-NoPancreatitis
6.988800E-01
Pancreatitis-vs-NoPancreatitis
2.499600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.263400E-01
Normal-vs-N1
7.933200E-01
N0-vs-N1
6.374400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.288000E-01
Normal-vs-TP53-NonMutant
2.475400E-01
TP53-Mutant-vs-TP53-NonMutant
3.75969999577563E-08
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
